ABSCI CORP Cash and Restricted Cash
ABSCI CORP (ABSI) had Cash and Restricted Cash of $108.92 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-11
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $108.92M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9.69M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $21.08M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $26.87M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $108.92M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $9.69M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $21.08M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $26.87M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $55.29M 10-Q · filed 2026-08-11 |
| 2025-03-31 | $64.13M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $58.21M 10-Q · filed 2026-08-11 |
| 2024-09-30 | $55.15M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $60.59M 10-Q · filed 2025-08-12 |
| 2024-03-31 | $76.31M 10-Q · filed 2025-05-13 |
| 2023-12-31 | $89.67M 10-K · filed 2026-03-24 |
| 2023-09-30 | $86.87M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $78.02M 10-Q · filed 2024-08-14 |
| 2023-03-31 | $28.32M 10-Q · filed 2024-05-14 |
| 2022-12-31 | $76.84M 10-K · filed 2025-03-18 |
| 2022-09-30 | $124.20M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $222.88M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $250.86M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $279.93M 10-K · filed 2024-03-21 |
| 2021-09-30 | $306.62M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $126.80M 10-Q · filed 2022-08-11 |
| 2021-03-31 | $185.12M 10-Q · filed 2022-05-11 |
| 2020-12-31 | $71.71M 10-K · filed 2023-03-30 |
| 2020-09-30 | $10.75M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $14.50M 10-Q · filed 2021-09-07 |
| 2019-12-31 | $13.88M 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |